Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT)’s Fate Therapeutics FATE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,422	Closed	-$36.5K	–	3590
2024 Q3	$36.5K	Sell	10,422 -24,712	-70%	-$96.2K	﹤0.01%	2905
2024 Q2	$115K	Buy	35,134 +23,824	+211%	+$104K	﹤0.01%	2573
2024 Q1	$83K	Sell	11,310 -41,132	-78%	-$255K	﹤0.01%	3371
2023 Q4	$196K	Sell	52,442 -335,814	-86%	-$793K	﹤0.01%	2796
2023 Q3	$823K	Buy	388,256 +209,609	+117%	+$694K	﹤0.01%	1819
2023 Q2	$850K	Buy	178,647 +161,873	+965%	+$893K	﹤0.01%	1364
2023 Q1	$95.6K	Sell	16,774 -475,208	-97%	-$2.87M	﹤0.01%	2129
2022 Q4	$4.96M	Buy	491,982 +468,892	+2,031%	+$8.81M	0.03%	668
2022 Q3	$517K	Buy	+23,090	New	+$667K	﹤0.01%	1453
2021 Q4	–	Sell	-12,958	Closed	-$768K	–	2655
2021 Q3	$768K	Sell	12,958 -9,578	-43%	-$751K	0.01%	1004
2021 Q2	$1.96M	Buy	22,536 +13,182	+141%	+$1.06M	0.02%	708
2021 Q1	$771K	Buy	+9,354	New	+$896K	0.01%	960
2020 Q1	–	Sell	-13,648	Closed	-$267K	–	1286
2019 Q4	$267K	Buy	+13,648	New	+$217K	0.01%	1274

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return